Mortgage rates backed down Monday, building a yo-yo pattern over the past week-plus that sits a bit below recent highs, when averages came close to their most expensive levels of the calendar year. Today’s National Mortgage Rate Averages After rising Friday, the only day last week that rates saw an upswing, mortgage averages fell back
In this article AMZN A rendering of ABL Space’s RS1 rocket launching Project Kuiper satellites for Amazon. Amazon Amazon aims to launch its first Project Kuiper internet satellites in the fourth quarter of 2022, the company announced on Monday. The technology giant filed a request with the Federal Communications Commission to launch and operate its
Take a look at some of the biggest movers in the premarket: Pfizer (PFE) – Pfizer jumped 4% in the premarket after the drugmaker reported better-than-expected profit and revenue for the third quarter. Pfizer earned $1.34 per share, 25 cents a share above estimates. The company also issued an improved full-year forecast on strong demand
Water has become a multi-billion dollar industry, so water stocks offer a solid investment case for long-term investors. Analysts are even debating whether freshwater could replace oil to become the world’s most critical resource. As climate change leads to rising global temperatures, demand for freshwater is primed to grow along with an expanding global population
The reason for investing in Ocugen (NASDAQ:OCGN) stock hasn’t changed. Bulls expect the FDA to allow Ocugen to market Bharat Biotech’s Covaxin vaccine in the U.S., enabling Ocugen to generate massive sales and rapidly boost OCGN stock. Source: shutterstock.com/PhotobyTawat The problems with this thesis, though, remain the same as they’ve ever been. Despite a great
Everyone hates bailouts — until you need one, that is. Real-estate conglomerate China Evergrande (OTCMKTS:EGRNF) could certainly use some assistance right about now, as could investors in EGRNF stock. Source: hxdbzxy / Shutterstock.com The stock has lost much of its value over the past several years, down 84% in the last 12 months alone. Knowing this,
In this article TSLA CNBC’s Jim Cramer expressed wonderment Monday at the continued strength in Tesla‘s stock — up about 50% in the past month and roughly 200% in the past 12 months. “Tesla is actually a phenomenon we have to talk about,” Cramer said on “Squawk on the Street,” before the opening bell on
In this article CLX NXPI CAR CHGG SPG James Tahaney loads textbooks on to a pallet in preparation for shipping at the Chegg warehouse in Shepherdsville, Kentucky, April 29, 2010. John Sommers II | Bloomberg | Getty Images Check out the companies making headlines after the bell: Chegg — Shares of Chegg sunk more than
Watch out — there’s a brand new cryptocurrency mining play on Wall Street. It’s Stronghold Digital Mining (NASDAQ:SDIG), which just recently introduced SDIG stock to the public for trading. But is this stock worth buying? Source: Shutterstock Maybe you have a cryptocurrency portfolio and want to add a miner or two to the mix. That’s
When it comes to protecting to the downside, something not everyone considers when in the midst of a bull market, investors in dividend stocks need to be aware of the volatility of their stocks. Owning too many high-risk positions can create a scenario where your portfolio loses more than the S&P 500 index. To help
SmileDirectClub (NASDAQ:SDC) is an oral care company founded in 2014. Headquartered in Nashville, the company operates in the North America, Europe and Asia Pacific regions. Its primary offering is a clear aligner therapy treatment, but it also sells a variety of oral care products, such as whitening kits and gels, toothbrushes, toothpastes and water flossers. SDC
The Ark Innovation ETF (NYSEARCA:ARKK) bought 2.1 million shares of Skillz (NYSE:SKLZ) on Oct. 21., according to 24/7 Wall St., the SKLZ stock buy brings the ETF’s total holdings of the esports gaming platform company to 13.3 million shares. Source: NYCStock / Shutterstock.com Although the SKILLZ position is only good for 0.70% of the ETF’s
Big Oil has been out of favor for over a decade. But on the reopen, are the analysts finally bullish? Visit our website: https://www.zacks.com Visit our Stocktwits account: https://stocktwits.com/ZacksResearch Check out our weekly promotion: https://www.zacks.com/promo If you’re interested in our services, please check out Zacks Ultimate: https://www.zacks.com/ultimate/?adid=YOUTUBE&cid=sm-YOUTUBE
Investors seeking exposure to the Hong Kong stock market might consider exchange-traded funds (ETFs). Historically, Hong Kong has thrived as a global financial center and capitalist economy, and it largely has continued to do so since it became a semi-autonomous region of China in 1997. But during the past two years, Hong Kong’s democratic government
Former hedge fund manager Nelson Saeirs’ paintings visually represent the volatility trading algorithms he used on Wall Street. This one is titled, “The VIX over 40.” A reading in the VIX volatility index over 40 has historically preceded huge market losses Source: Nelson Saiers If there ever was a year active management should have outperformed
Barry Silbert, Founder and CEO, Digital Currency Group David A. Grogan | CNBC Digital Currency Group is selling shares to SoftBank and Google’s venture capital arm in a deal that values the crypto conglomerate at more than $10 billion. The Manhattan-based, private company announced a secondary round on Monday, in which existing investors are selling
Take a look at some of the biggest movers in the premarket: Harley-Davidson (HOG) – The motorcycle maker’s shares soared 9.4% in the premarket after the U.S. and the European Union ended a dispute involving steel and aluminum tariffs. Harley could have paid European tariffs of 56% if the dispute had not been resolved. Spotify
Given the potential, tremendous benefits of Cassava’s Alzheimer’s drug for millions of patients and the high probability of the drug being approved, I believe that Cassava Sciences (NASDAQ:SAVA) stock is vastly undervalued. Source: Pavel Kapysh / Shutterstock.com Additionally, my calculations indicate that the shares could easily soar over 200x after the company’s Alzheimer’s treatment, simufilam,
On Oct. 27, Ocugen (NASDAQ:OCGN) confirmed the truth of a point I’ve been making for many months: the FDA will require the company to conduct a U.S.-based trial of Covaxin before the agency will even consider approving it. Specifically, on Oct. 27, Ocugen announced that it had submitted an application to the FDA to conduct
Early in October, I said that Cassava Sciences’ (NASDAQ:SAVA) big gains in late September had investors dreaming of a big payday for SAVA stock in 2022. Source: Pavel Kapysh / Shutterstock.com I even suggested it might retest $100—a level it hit throughout the summer—by the end of 2021. I was convinced it would go on